Net Income (Loss) Attributable to Parent in USD of Vaxcyte, Inc. from 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vaxcyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to Q3 2025.
  • Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$213M, a 106% decline year-over-year.
  • Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$657M, a 29.5% decline year-over-year.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$464M, a 15.3% decline from 2023.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$402M, a 80% decline from 2022.
  • Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 123% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Vaxcyte, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$657M -$213M -$110M -106% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 -$547M -$167M -$37.9M -29.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-04
Q1 2025 -$510M -$141M -$45.7M -48.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-04
Q4 2024 -$464M -$137M +$43.7M +24.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 -$508M -$103M -$10.5M -11.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 -$497M -$129M -$60.4M -88.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-04
Q1 2024 -$437M -$95M -$34.6M -57.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-04
Q4 2023 -$402M -$181M -$103M -132% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 -$300M -$92.7M -$34.7M -60% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$265M -$68.3M -$19.8M -40.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-05
Q1 2023 -$245M -$60.5M -$21.5M -55.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-05
Q4 2022 -$223M -$78.1M -$49.5M -173% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 -$174M -$57.9M -$31.3M -118% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$143M -$48.5M -$24.9M -105% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$118M -$39M -$17.8M -83.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$100M -$28.6M -$7.83M -37.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$92.3M -$26.6M -$5.6M -26.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$86.7M -$23.7M -$3.36M -16.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$83.3M -$21.2M +$5.92M +21.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$89.2M -$20.7M -$6.12M -41.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-29
Q3 2020 -$83.1M -$21M -$9.7M -85.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$73.4M -$20.3M -$9.66M -90.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$63.7M -$27.1M -$13.5M -98.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$50.3M -$14.6M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$11.3M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-29
Q2 2019 -$10.7M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-29
Q1 2019 -$13.7M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-29

Vaxcyte, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$464M -$61.7M -15.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$402M -$179M -80% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$223M -$123M -123% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$100M -$10.9M -12.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$89.2M -$38.9M -77.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$50.3M -$20.8M -70.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$29.5M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.